type |
Ex - Dividend Date |
payment date |
value |
|---|---|---|---|
| Dividends | 12/16/2025 | 12/19/2025 | 0.31981000 |
| Dividends | 12/17/2024 | 12/20/2024 | 0.10100000 |
| Dividends | 12/21/2023 | 12/27/2023 | 0.006300 |
| Dividends | 06/08/2023 | 06/13/2023 | 0.008240 |
| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| PRAX | Stock | Healthcare | US$ 9.82 B | 5,24% | |
| DNTH | Stock | Healthcare | US$ 5.91 B | 4,99% | |
| ACAD | Stock | Healthcare | US$ 4.83 B | 4,91% | |
| SRRK | Stock | Healthcare | US$ 6.74 B | 4,76% | |
| XENE | Stock | Healthcare | US$ 5.85 B | 4,37% | |
| ARGX | Stock | Healthcare | US$ 65.51 B | 4,35% | |
| ARWR | Stock | Healthcare | US$ 12.20 B | 4,27% | |
| BIIB | Stock | Healthcare | US$ 32.63 B | 4,17% | |
| ALKS | Stock | Healthcare | US$ 7.73 B | 4,16% | |
| PTCT | Stock | Healthcare | US$ 5.78 B | 3,75% | |
| NBIX | Stock | Healthcare | US$ 15.82 B | 3,60% | |
| DNLI | Stock | Healthcare | US$ 3.56 B | 3,48% | |
| EWTX | Stock | Healthcare | US$ 4.56 B | 3,33% | |
| DYN | Stock | Healthcare | US$ 4.53 B | 3,33% | |
| AXSM | Stock | Healthcare | US$ 10.91 B | 3,29% | |
| AXGN | Stock | Healthcare | US$ 2.53 B | 2,59% | |
Sk Biopharmaceuticals Co Ltd
|
326030 | Stock | Healthcare | US$ 6.78 T | 2,55% |
| SUPN | Stock | Healthcare | US$ 2.53 B | 2,39% | |
| SRPT | Stock | Healthcare | US$ 2.43 B | 2,17% | |
Biohaven Ltd.
|
BHVN | Stock | Healthcare | US$ 2.37 B | 1,99% |
H Lundbeck A/S
|
HLUN-B | Stock | Healthcare | US$ 43.77 B | 1,80% |
| NEU | Stock | Healthcare | US$ 2.58 B | 1,57% | |
BioArctic AB (publ)
|
BIOA-B | Stock | Healthcare | US$ 29.64 B | 1,43% |
Rapport Therapeutics, Inc. Common Stock
|
RAPP | Stock | Healthcare | US$ 2.20 B | 1,39% |
| TSHA | Stock | Healthcare | US$ 1.81 B | 1,36% | |
Idorsia Ltd
|
IDIA | Stock | Healthcare | US$ 1.39 B | 1,12% |
| IART | Stock | Healthcare | US$ 1.30 B | 1,11% | |
Alto Neuroscience, Inc.
|
ANRO | Stock | Healthcare | US$ 1.40 B | 1,11% |
|
LB Pharmaceuticals Inc Common Stock
|
LBRX | Stock | Healthcare | US$ 1.53 B | 0,98% |
| SLDB | Stock | Healthcare | US$ 1.10 B | 0,78% | |
|
Dynavox Group
|
DYVOX | Stock | Healthcare | US$ 8.17 B | 0,77% |
| ANNX | Stock | Healthcare | US$ 917.56 M | 0,70% | |
|
Oncolys Biopharma Inc
|
4588 | - | Healthcare | - | 0,67% |
Medincell SA
|
MEDCL | Stock | Healthcare | US$ 818.74 M | 0,65% |
CeriBell, Inc
|
CBLL | Stock | Healthcare | US$ 948.71 M | 0,61% |
| DSGN | Stock | Healthcare | US$ 940.60 M | 0,57% | |
|
Bright Minds Biosciences Inc
|
DRUG | Stock | Healthcare | US$ 697.83 M | 0,54% |
| CAPR | Stock | Healthcare | US$ 546.51 M | 0,53% | |
|
Neurogene Inc
|
NGNE | Stock | Healthcare | US$ 772.44 M | 0,48% |
| OVID | Stock | Healthcare | US$ 542.93 M | 0,46% | |
| PRTA | Stock | Healthcare | US$ 504.13 M | 0,45% | |
| RGNX | Stock | Healthcare | US$ 607.32 M | 0,44% | |
| BWAY | Stock | Healthcare | US$ 568.94 M | 0,42% | |
| BNTC | Stock | Healthcare | US$ 427.37 M | 0,42% | |
| RLMD | Stock | Healthcare | US$ 466.15 M | 0,41% | |
| CLPT | Stock | Healthcare | US$ 425.84 M | 0,40% | |
Neuropace Inc
|
NPCE | Stock | Healthcare | US$ 506.28 M | 0,39% |
|
Zylox-Tonbridge Med Tech Co
|
2190 | Stock | Healthcare | US$ 7.28 B | 0,37% |
|
Sanbio Company Limited
|
4592 | - | Healthcare | - | 0,34% |
|
MicroPort NeuroTech Ltd
|
2172 | Stock | Healthcare | US$ 4.58 B | 0,33% |
| VNDA | Stock | Healthcare | US$ 322.87 M | 0,31% | |
|
Peijia Medical Ltd
|
9996 | Stock | Healthcare | US$ 3.38 B | 0,30% |
|
Newron Pharmaceuticals SpA
|
NWRN | Stock | Healthcare | US$ 250.09 M | 0,27% |
| AVXL | Stock | Healthcare | US$ 265.11 M | 0,26% | |
|
Santhera Pharmaceuticals Holding AG
|
SANN | Stock | Healthcare | US$ 239.11 M | 0,24% |
| IKT | Stock | Healthcare | US$ 348.84 M | 0,23% | |
| TNXP | Stock | Healthcare | US$ 229.31 M | 0,23% | |
| LRMR | Stock | Healthcare | US$ 397.87 M | 0,20% | |
| ALEC | Stock | Healthcare | US$ 274.68 M | 0,20% | |
| ABOS | Stock | Healthcare | US$ 223.46 M | 0,19% | |
PepGen Ltd
|
PEPG | Stock | Healthcare | US$ 220.99 M | 0,19% |
| VYGR | Stock | Healthcare | US$ 208.27 M | 0,18% | |
| ACIU | Stock | Healthcare | US$ 291.32 M | 0,17% | |
Entrada Therapeutics Inc
|
TRDA | Stock | Healthcare | US$ 279.18 M | 0,16% |
|
MYUNG IN PHARMA CO LTD
|
317450 | Stock | Healthcare | US$ 651.89 B | 0,12% |
|
MapLight Therapeutics, Inc. Common Stock
|
MPLT | Stock | Healthcare | US$ 638.62 M | 0,10% |
Neumora Therapeutics, Inc.
|
NMRA | Stock | Healthcare | US$ 253.66 M | 0,10% |
Cognition Therapeutics Inc
|
CGTX | Stock | Healthcare | US$ 97.95 M | 0,08% |
Average Investor10 user rating
4.0
(1 people)
iShares Trust - iShares Neuroscience and Healthcare ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $7.21 million.
Over the past 12 months, iShares Trust - iShares Neuroscience and Healthcare ETF recorded a return of 37.45%, with its price trading between $25.57 and $40.67 during the same period.
The ETF is traded under the ticker IBRN.
The current price of IBRN is $35.19. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
IBRN is currently trading at $35.19, with a market capitalization of approximately $7.207.438,00. Over the past year, the ETF has delivered a 37.45% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in IBRN through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol IBRN, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, IBRN has returned -11.25%, and 37.45% over the past year.
If you were to purchase 100 shares of IBRN at the current price of $35.19, your total investment would be $3,519.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
